Publications by authors named "Shinpei Harada"

Claim this Profile
E
Event-free survival at 36 months is a suitable endpoint for diffuse large B-cell lymphoma patients treated with immunochemotherapy: real-world evidence from the North Japan Hematology Study Group.
Koh Izumiyama, Tasuku Inao, Hideki Goto, Shinpei Harada, Hajime Senjo

Haematologica· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Calcineurin inhibitor inhibits tolerance induction by suppressing terminal exhaustion of donor T cells after allo-HCT.
Hajime Senjo, Shinpei Harada, Shimpei I Kubota, Yuki Tanaka, Takahiro Tateno

Blood· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reactive granulopoiesis depends on T-cell production of IL-17A and neutropenia-associated alteration of gut microbiota.
Xuanzhong Chen, Daigo Hashimoto, Ko Ebata, Shuichiro Takahashi, Yu Shimizu, Shinpei Harada

Proc Natl Acad Sci U S A· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic change in peripheral blood WT1 mRNA levels within three cycles of azacitidine predict treatment response in patients with high-risk myelodysplastic syndromes.
Shinpei Harada, Masahiro Onozawa, Daisuke Hidaka, Shota Yokoyama, Hajime Senjo

Ann Hematol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Successful treatment with gilteritinib for relapsed acute myeloid leukemia with FLT3-N676K mutation].
Toru Miyajima, Shinpei Harada, Reiki Ogasawara, Emi Yokoyama, Koh Izumiyama

Rinsho Ketsueki· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myelomonocytic differentiation of leukemic blasts accompanied by differentiation syndrome in a case of -ITD-positive AML treated with gilteritinib.
Takeshi Kondo, Masahiro Onozawa, Shinichi Fujisawa, Shinpei Harada, Reiki Ogasawara

Hematology· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Emergence of mutation in the colony-stimulating factor 3 receptor gene during follow-up of unclassifiable myeloproliferative neoplasm].
Shinpei Harada, Kohei Okada, Shota Yokoyama, Daisuke Hidaka, Eiko Hayase

Rinsho Ketsueki· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disseminated Gonococcal Infection Associated with Eculizumab Therapy for Paroxysmal Nocturnal Hemoglobinuria: A Case Report and Literature Review.
Makoto Saito, Shinpei Harada, Reiki Ogasawara, Koh Izumiyama, Akio Mori

Int J Gen Med· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Takotsubo cardiomyopathy developing during anagrelide therapy in a patient with essential thrombocythemia].
Takahiro Nagashima, Shinpei Harada, Hiroyuki Kimura

Rinsho Ketsueki· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful Treatment of Gastrosplenic Fistula Arising from Diffuse Large B-Cell Lymphoma with Chemotherapy: Two Case Reports.
Makoto Saito, Kencho Miyashita, Yosuke Miura, Shinpei Harada, Reiki Ogasawara

Case Rep Oncol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete remission of angiolymphoid hyperplasia with eosinophilia using topical tacrolimus.
Shinpei Harada, Toshifumi Nomura, Toshinari Miyauchi, Satoru Shinkuma, Yasuyuki Fujita

Eur J Dermatol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis